Hefei Lifeon Pharmaceutical Dividend
Dividend criteria checks 2/6
Hefei Lifeon Pharmaceutical is a dividend paying company with a current yield of 2.3% that is well covered by earnings.
Key information
2.3%
Dividend yield
42%
Payout ratio
Industry average yield | 1.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | CN¥1.00 |
Dividend yield forecast in 3Y | 2.3% |
Recent dividend updates
Recent updates
Hefei Lifeon Pharmaceutical (SZSE:003020) Has Announced A Dividend Of CN¥0.50
May 23Investors Still Aren't Entirely Convinced By Hefei Lifeon Pharmaceutical Co., Ltd.'s (SZSE:003020) Earnings Despite 25% Price Jump
May 22Hefei Lifeon Pharmaceutical's (SZSE:003020) Profits May Not Reveal Underlying Issues
Apr 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 003020 has been paying a dividend for less than 10 years.
Growing Dividend: 003020's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
Hefei Lifeon Pharmaceutical Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (003020) | 2.3% |
Market Bottom 25% (CN) | 0.7% |
Market Top 25% (CN) | 2.5% |
Industry Average (Pharmaceuticals) | 1.9% |
Analyst forecast in 3 Years (003020) | 2.3% |
Notable Dividend: 003020's dividend (2.3%) is higher than the bottom 25% of dividend payers in the CN market (0.7%).
High Dividend: 003020's dividend (2.3%) is low compared to the top 25% of dividend payers in the CN market (2.55%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (41.7%), 003020's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (642.8%), 003020's dividend payments are not well covered by cash flows.